This could indicate that the T1D-risk allotype (PTPN22620W) enhances NOD2 activity to suppress gastrointestinal pathology, however, more studies are necessary to clarify how PTPN22620W alters NOD2 response compared to PTPN22620R. This evidence concerns the gene NOD2 and type 1 diabetes mellitus.